Literature DB >> 12566314

UBP41 is a proapoptotic ubiquitin-specific protease.

Andreas Gewies1, Stefan Grimm.   

Abstract

We have isolated Ubp41, a ubiquitin-specific protease, in a screen for proapoptoticgenes. We found that overexpression of Ubp41 is sufficient to elicit all features of apoptosis in human cells. In contrast, an enzymatically defective UBP41 mutant and homologous ubiquitin-processing protease family members did not significantly induce cell death. Overexpression of Ubp41 resulted in a strong deubiquitination of a broad range of proteins, but surprisingly did not lead to a stabilization of protein substrates known to be regulated by the ubiquitin-proteasome system such as the cell cycle factors p21 and p27. Hence, in contrast to the proteasome inhibitor MG132, Ubp41 overexpression did not arrest cells in G(2)/M. Rather, overexpression of hUbp41 seems to interfere with the ubiquitin-system and to cause the activation of apoptosis pathways by stabilizing specific substrates. Hence, for the first time we found that a member of the deubiquitinating enzymes has a direct proapoptotic activity additionally tightening the connection between apoptosis and the ubiquitin-proteasome system.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12566314

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  17 in total

Review 1.  The role of deubiquitinating enzymes in apoptosis.

Authors:  Suresh Ramakrishna; Bharathi Suresh; Kwang-Hyun Baek
Journal:  Cell Mol Life Sci       Date:  2010-08-21       Impact factor: 9.261

2.  Approaching the self-incompatibility locus Z in rye (Secale cereale L.) via comparative genetics.

Authors:  B Hackauf; P Wehling
Journal:  Theor Appl Genet       Date:  2005-02-17       Impact factor: 5.699

Review 3.  Deubiquitinating enzymes as novel anticancer targets.

Authors:  Benjamin Nicholson; Jeffrey G Marblestone; Tauseef R Butt; Michael R Mattern
Journal:  Future Oncol       Date:  2007-04       Impact factor: 3.404

4.  Control of AIF-mediated cell death by antagonistic functions of CHIP ubiquitin E3 ligase and USP2 deubiquitinating enzyme.

Authors:  K H Oh; S W Yang; J M Park; J H Seol; S Iemura; T Natsume; S Murata; K Tanaka; Y J Jeon; C H Chung
Journal:  Cell Death Differ       Date:  2011-02-04       Impact factor: 15.828

5.  Positive symptoms of psychosis correlate with expression of ubiquitin proteasome genes in peripheral blood.

Authors:  Chad A Bousman; Gursharan Chana; Stephen J Glatt; Sharon D Chandler; Todd May; James Lohr; William S Kremen; Ming T Tsuang; Ian P Everall
Journal:  Am J Med Genet B Neuropsychiatr Genet       Date:  2010-10-05       Impact factor: 3.568

6.  De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF.

Authors:  A-L Mahul-Mellier; E Pazarentzos; C Datler; R Iwasawa; G AbuAli; B Lin; S Grimm
Journal:  Cell Death Differ       Date:  2011-12-16       Impact factor: 15.828

7.  Gene structure, alternate splicing, tissue distribution, cellular localization, and developmental expression pattern of mouse deubiquitinating enzyme isoforms Usp2-45 and Usp2-69.

Authors:  Natalia Gousseva; Rohan T Baker
Journal:  Gene Expr       Date:  2003

8.  Macrophage ubiquitin-specific protease 2 contributes to motility, hyperactivation, capacitation, and in vitro fertilization activity of mouse sperm.

Authors:  Mayuko Hashimoto; Shunsuke Kimura; Chihiro Kanno; Yojiro Yanagawa; Takafumi Watanabe; Jun Okabe; Eiki Takahashi; Masashi Nagano; Hiroshi Kitamura
Journal:  Cell Mol Life Sci       Date:  2020-10-26       Impact factor: 9.261

Review 9.  Paradoxical roles of caspase-3 in regulating cell survival, proliferation, and tumorigenesis.

Authors:  Ebrahim Eskandari; Connie J Eaves
Journal:  J Cell Biol       Date:  2022-05-12       Impact factor: 8.077

10.  Isolation of ORCTL3 in a novel genetic screen for tumor-specific apoptosis inducers.

Authors:  S Irshad; A-L Mahul-Mellier; N Kassouf; A Lemarie; S Grimm
Journal:  Cell Death Differ       Date:  2009-03-13       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.